Oregon Public Employees Retirement Fund
NKTR icon

Oregon Public Employees Retirement Fund’s Nektar Therapeutics NKTR Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,157
Closed -$43.8K – 1702
2023
Q1 		$43.8K Sell
4,157
-11
-0.3% -$333 ﹤0.01% 1686
2022
Q4 		$141K Buy
4,168
+85
+2% +$4.11K ﹤0.01% 1639
2022
Q3 		$196K Buy
4,083
+9
+0.2% +$535 ﹤0.01% 1561
2022
Q2 		$232K Sell
4,074
-567
-12% -$35.8K ﹤0.01% 1381
2022
Q1 		$375K Buy
4,641
+641
+16% +$94.9K ﹤0.01% 1482
2021
Q4 		$811K Sell
4,000
-90
-2% -$19.5K 0.01% 1109
2021
Q3 		$1.1M Sell
4,090
-54
-1% -$13K 0.01% 936
2021
Q2 		$1.07M Buy
4,144
+195
+5% +$54K 0.01% 993
2021
Q1 		$1.19M Hold
3,949
– – 0.01% 915
2020
Q4 		$1.01M Sell
3,949
-76
-2% -$19.6K 0.01% 911
2020
Q3 		$1M Sell
4,025
-336
-8% -$106K 0.01% 766
2020
Q2 		$1.51M Sell
4,361
-27
-0.6% -$8.43K 0.02% 590
2020
Q1 		$1.18M Sell
4,388
-33
-0.7% -$10.2K 0.02% 637
2019
Q4 		$1.43M Buy
4,421
+3,245
+276% +$941K 0.02% 718
2019
Q3 		$321K Sell
1,176
-41
-3% -$15K ﹤0.01% 1400
2019
Q2 		$650K Buy
1,217
+7
+0.6% +$3.51K 0.01% 1170
2019
Q1 		$610K Sell
1,210
-328
-21% -$194K 0.01% 1177
2018
Q4 		$758K Sell
1,538
-2,495
-62% -$1.51M 0.01% 1029
2018
Q3 		$3.69M Buy
4,033
+29
+0.7% +$24.8K 0.05% 373
2018
Q2 		$2.93M Buy
+4,004
New +$4.62M 0.04% 444

Other funds holding NKTR

Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Oregon Public Employees Retirement Fund's NKTR Position: Q2 2023 in Review

Oregon Public Employees Retirement Fund sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 4,157 shares — an estimated $43.8K sold.

Oregon Public Employees Retirement Fund first reported a position in NKTR in Q2 2018 and held it in 20 quarters. The position peaked at $3.69M in Q3 2018. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.

  • Oregon Public Employees Retirement Fund reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 4,157 Nektar Therapeutics shares in Q2 2023, an estimated $43.8K.
  • Oregon Public Employees Retirement Fund first reported a position in Nektar Therapeutics in Q2 2018 and held it in 20 quarters.
  • Oregon Public Employees Retirement Fund's Nektar Therapeutics position peaked at $3.69M in Q3 2018.
  • 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2023, filed 26 Jul 2023.